|
|
Post by cretin11 on Oct 25, 2019 10:58:47 GMT -5
Thank you for the clarifications/corrections of the misinformation, mnholdem.
|
|
|
|
Post by sportsrancho on Oct 25, 2019 11:05:49 GMT -5
JUDY is a nut case. Why she is continually slandering and bashing is anybody’s guess. I was not in a group who blamed Mike for anything. I had a few thousand dollars worth of options ..most of the money I lost was in my Roth because I had to sell my shares for a medical emergency ..she has taken the things I privately told her about my personal life and turn them into some kind of conspiracy theory.
There were a group of people that did want to post emails on Pro-Boards. I was not in that group. I don’t have an email from Mike that promised me anything. JUDY was mad at Mike and wanted to post an email herself ..all I did was tell her maybe you should wait and post them at the same time these other people are. She was upset at Mike and I actually did not think it was a real big deal and kind of hoped she’d just get over it.
If she wants these people to post those emails on Stocktwits I’m sure they’ll be glad to oblige her....but is that really where we want to go?
Yes I’ve known Bill for years.
Yes I trade for other people.
No I did not lose my house, I moved out of an apartment.
No I do not own stock in VDex.
Mike C and I talked about all of the nonsense. He’s well aware that the group of people with the emails had to do with the Christmas massacre, and nothing to do with Vdex, or anyone at Vdex.
|
|
|
|
Post by wsulylecoug on Oct 25, 2019 11:44:26 GMT -5
It's pretty apparent there are multiple smear campaigns going on. There are polarizing personalities on both sides. With all due respect MN, statements like "I certainly hope that it's not being endorsed in any way by management..." probably isn't helping. I'm trying to stay as neutral as possible because there are people I've come to respect on both sides of the battle lines. In my view it is a battle and there are so many blurred lines to the average Joe that it becomes difficult to know who or what to root for...other than growing scripts and PPS. Don't mean to offend with any statements above, but wouldn't it be great to sit back and let the processes at work right now just do their thing and see what happens? I appreciate an update now and then, but unfortunately it always seems to be followed up by conjectures and mud slinging.
|
|
|
|
Post by sportsrancho on Oct 25, 2019 13:46:55 GMT -5
But yet it’s a very fair statement and at the root of this battle.
|
|
|
|
Post by wsulylecoug on Oct 25, 2019 14:21:36 GMT -5
Don’t get me wrong, not saying it’s an unfair statement, but I’m sort of tired of the smearing from all directions and those kinds of statements just fan the flames...just one persons opinion.
|
|
|
|
Post by mnkdfann on Oct 25, 2019 14:31:29 GMT -5
Bill was working WITH MannKind and not trying to fly "under the radar" as this poster accuses them of doing. Mr. McCullough has business contacts worldwide and hooked up some of them with Joseph Saldanha, who was MannKind's VP of Marketing. People in the UAE expressed interest and Bill brought them to MannKind. How is that flying under the radar or somehow indicates a nefarious intent? Incidentally, for those of you who didn't know Joe, here is his bio (contained in a MannKind press release from April 19, 2016): "Mr. Saldanha has worked in the diabetes space for over 13 years, in both U.S. and global roles. He has experience marketing oral anti-diabetic medications, insulins (both injectable and inhaled), and medical devices. Mr. Saldanha commercialized Sanofi's Lantus® in the Intercontinental Region. After returning to the U.S., he was part of the team that commercialized the Lantus SoloSTAR® pen. In addition to heading up Sanofi's strategy and medical education teams, he was responsible for all hospital business. Mr. Saldanha launched an initiative with Certified Diabetes Educators® to train patients in diabetes and the appropriate use of insulin. Prior to that, Mr. Saldanha served as Director of Business Development for the insulin delivery device business at Johnson and Johnson Diabetes (LifeScan®/Animas®). More recently, he worked in the biosimilars business with Pfizer in New York. Mr. Saldanha holds a Bachelor of Science from Drexel University and a Master of Science from the University of Pennsylvania."Today Mr. Saldanha is apparently Chief Business Officer, Valeritas Holdings Inc. That looks to me like a big step down (compared to Mannkind). I'm willing to believe Mr. Saldanha is a good guy and does good work. I've no reason to believe otherwise. But his career trajectory suggests to me that maybe his peers and his industry don't put him on the same pedestal some others have. |
|
|
|
Post by akemp3000 on Oct 25, 2019 14:36:27 GMT -5
Campaigns, battles, smears or not, to date this appears to be nothing more than a cyber war of words without any weapons or ammo and one in which one side is wanting to do battle while the other side, Mannkind management, is simply ignoring the noise. IMO, a serious battle would require an aggressive announcement from a nationally respected investor. That would certainly light everything up.
|
|
|
|
Post by sportsrancho on Oct 25, 2019 15:17:18 GMT -5
It sure would😁
|
|
|
|
Post by mnholdem on Oct 25, 2019 16:12:37 GMT -5
Campaigns, battles, smears or not, to date this appears to be nothing more than a cyber war of words without any weapons or ammo and one in which one side is wanting to do battle while the other side, Mannkind management, is simply ignoring the noise. IMO, a serious battle would require an aggressive announcement from a nationally respected investor. That would certainly light everything up. There’s ammo but, to use your soliloquy for a moment... You have a king locked up in his castle while his subjects are starving. After years of taxation (dilution) and starvation (erosion of shareholder value) the subjects...by now mostly peasants... rise up and demand their fair share. It’s the subjects whose work made the king rich. It’s the subjects who financed what could become a prosperous kingdom. The king may hide behind what he believes are impenetrable walls, dining on quail and pheasant. Little does he realize that his walls are not impenetrable. He knows what he needs to do but he, unfortunately, does not possess the character of what most consider to be a true king. |
|
|
|
Post by wsulylecoug on Oct 25, 2019 16:25:41 GMT -5
Actions speak louder than words...
MC and the C team...do what you believe is best for your mission
MK and HfM...do what you believe is best for your mission
BM and VDex...do what you believe is best for your mission
If everyone sticks to those actions, it will shake out in the end.
For me personally, coming to the MNKD Proboards site has lost much of its draw...it’s been more about AMRN and SENS for me lately. I hope it gets back to what originally drew me here.
Peace...
|
|
|
|
Post by agedhippie on Oct 25, 2019 16:50:48 GMT -5
Today Mr. Saldanha is apparently Chief Business Officer, Valeritas Holdings Inc. That looks to me like a big step down (compared to Mannkind). I'm willing to believe Mr. Saldanha is a good guy and does good work. I've no reason to believe otherwise. But his career trajectory suggests to me that maybe his peers and his industry don't put him on the same pedestal some others have. That's an interesting product and I thought it would do well when it was launched. Insurance coverage was a problem though. They classed it as a pump which meant it hit all the restrictions that a proper pump has so it rather ran into the sand despite being a lot cheaper. I suspect that ultimately the insurers were less concerned with price than that if they conceded the V-Go it would be used as a stalking horse by Medtronics and others (... you approved V-Go which is a pump for Type 2 ...) so the blocked it. |
|
|
|
Post by mnholdem on Oct 25, 2019 17:09:49 GMT -5
Bill was working WITH MannKind and not trying to fly "under the radar" as this poster accuses them of doing. Mr. McCullough has business contacts worldwide and hooked up some of them with Joseph Saldanha, who was MannKind's VP of Marketing. People in the UAE expressed interest and Bill brought them to MannKind. How is that flying under the radar or somehow indicates a nefarious intent? Incidentally, for those of you who didn't know Joe, here is his bio (contained in a MannKind press release from April 19, 2016): "Mr. Saldanha has worked in the diabetes space for over 13 years, in both U.S. and global roles. He has experience marketing oral anti-diabetic medications, insulins (both injectable and inhaled), and medical devices. Mr. Saldanha commercialized Sanofi's Lantus® in the Intercontinental Region. After returning to the U.S., he was part of the team that commercialized the Lantus SoloSTAR® pen. In addition to heading up Sanofi's strategy and medical education teams, he was responsible for all hospital business. Mr. Saldanha launched an initiative with Certified Diabetes Educators® to train patients in diabetes and the appropriate use of insulin. Prior to that, Mr. Saldanha served as Director of Business Development for the insulin delivery device business at Johnson and Johnson Diabetes (LifeScan®/Animas®). More recently, he worked in the biosimilars business with Pfizer in New York. Mr. Saldanha holds a Bachelor of Science from Drexel University and a Master of Science from the University of Pennsylvania."Today Mr. Saldanha is apparently Chief Business Officer, Valeritas Holdings Inc. That looks to me like a big step down (compared to Mannkind). I'm willing to believe Mr. Saldanha is a good guy and does good work. I've no reason to believe otherwise. But his career trajectory suggests to me that maybe his peers and his industry don't put him on the same pedestal some others have. The topic was what Joe was pulling together at MannKind, which was a deal to bring Afrezza into a country that attracts patients from the entire Middle East to their medical centers. I would also add another thought. Joe was putting this deal together while Pfeffer was still CEO. Castagna took over a squashed it. Why would Joe quit a great job with MannKind unless he saw no future for him under the new CEO? IMO the deal was fantastic. But it was Pfeffer pulling it together. IMO Castagna wanted to feather his own cap. UAE simply wasn’t his feather. |
|
|
|
Post by ktim on Oct 25, 2019 17:46:48 GMT -5
Today Mr. Saldanha is apparently Chief Business Officer, Valeritas Holdings Inc. That looks to me like a big step down (compared to Mannkind). I'm willing to believe Mr. Saldanha is a good guy and does good work. I've no reason to believe otherwise. But his career trajectory suggests to me that maybe his peers and his industry don't put him on the same pedestal some others have. The topic was what Joe was pulling together at MannKind, which was a deal to bring Afrezza into a country that attracts patients from the entire Middle East to their medical centers. I would also add another thought. Joe was putting this deal together while Pfeffer was still CEO. Castagna took over a squashed it. Why would Joe quit a great job with MannKind unless he saw no future for him under the new CEO? IMO the deal was fantastic. But it was Pfeffer pulling it together. IMO Castagna wanted to feather his own cap. UAE simply wasn’t his feather. Obviously if that had the potential to be lucrative Mike's cap would have had a heck of a lot more plumage at this point if he'd done it... less dilution, higher stock price. Almost every executive wants to have a track record they can point too. I guess you're primarily saying Mike didn't have the judgement to see what would get him the track record he was seeking? Having no insight into the deal, I personally wouldn't weigh in on whether it was that, or if as Mike contends, it simply wasn't a good business deal. |
|
|
|
Post by mnholdem on Oct 25, 2019 21:15:23 GMT -5
Exactly! Castagna could have grabbed the brass ring by bringing in the UAE deal. It need not have been exclusive which would have left the door open for larger regional partnerships in the future of which, obviously, none have materialized.
|
|
|
|
Post by mnkdfann on Oct 25, 2019 21:36:06 GMT -5
Exactly! Castagna could have grabbed the brass ring by bringing in the UAE deal. It need not have been exclusive which would have left the door open for larger regional partnerships in the future of which, obviously, none have materialized. Or, "as Mike contends, it simply wasn't a good business deal". I suppose it depends on who you believe. From what I've been presented, I've personally no reason to believe Mike and the board were not justified in deciding that the deal was lacking. (Mike previously posted why he / they thought the deal was not in Mannkind's best interests.) |
|
